Back to Dividend Stocks
SN.L

Smith & Nephew plc

EURO STOXX 600
SN.L|Healthcare|Medical Devices|£12.03|P/E 22.7|MCap 10.2B|LSE

Last update: Mar 25, 2026 at 04:53

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Dividend Overview

Dividend Yield

2.40%

Annual Dividend

£0.29

Frequency

Semi-Annual

Payout Ratio

52.72%

FCF Payout Ratio

81.17%

Stock Price

£12.03

52-Week Range

£9.38 £14.41

Dividend Health Score

69/ 100Safe

SN.L's dividend appears safe and well-supported. Strengths include a 52.7% earnings payout ratio & 34.1% cfo payout ratio. Areas of concern: 81.2% fcf payout ratio & Volatile profit margin stability.

Based on 15 of 15 metrics

Payout & Coverage

Safe
Earnings Payout Ratio
52.7%Safe
FCF Payout Ratio
81.2%Warning
CFO Payout Ratio
34.1%Safe
Interest Coverage
5.4xSafe

Balance Sheet

Safe
Net Debt / Total Assets
26.5%Safe
Current Ratio
2.6xVery Safe
Debt-to-Equity
62.9Safe

Profitability

Caution
Return on Equity
11.8%Caution
Operating Margin
14.0%Caution
Gross Margin
75.3%Very Safe
Profit Margin Stability
VolatileWarning

Dividend Track Record

Safe
Dividend Streak
11+ yrsVery Safe
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
-0.7%Danger
Earnings Stability
GrowingVery Safe

Dividend History (2016–2025)

SN.L annual dividend per share and yield history

Earnings & Profitability

SN.L earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

March 26, 2026

Next Payment Date

Dividend Growth

3-Year Dividend CAGR

-2.91%

5-Year Dividend CAGR

-0.74%

10-Year Dividend CAGR

8.79%

3-Year Total Growth

-8.49%

5-Year Total Growth

-3.62%

10-Year Total Growth

132.19%

Income Calculator

SN.L Dividend Calculator

Total Investment

£1,202.50

Annual Income

£28.74

Quarterly Income

£7.19

Monthly Income

£2.40

Similar Dividend Stocks

StockYield5Y CAGRPrice
SN.L
SN.L
2.40%-0.74%£12.03
CTEC.L
CTEC.L
2.29%2.74%£2.23
HIK.L
HIK.L
4.99%12.07%£12.29

Frequently Asked Questions

What is SN.L's current dividend yield?
Smith & Nephew plc (SN.L) currently has a dividend yield of 2.40%, based on a stock price of £12.03 and an annual dividend of £0.29.
When is SN.L's next dividend payment date?
SN.L's next ex-dividend date is 2026-03-26 and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does SN.L pay in dividends per year?
Smith & Nephew plc paid £0.29 per share in annual dividends in 2025. The dividends are paid semi-annual.
Has SN.L been increasing its dividend?
Smith & Nephew plc has grown its dividend at a 5-year CAGR of -0.74% and a 10-year CAGR of 8.79%.
Is SN.L's dividend safe?
Smith & Nephew plc has a payout ratio of 52.72%. Its free cash flow payout ratio is 81.17%. A payout ratio below 60% is generally considered sustainable.
How is SN.L's Dividend Health Score calculated?
The Dividend Health Score evaluates Smith & Nephew plc's dividend sustainability across four categories: Payout & Coverage (40%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (20%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track SN.L Dividends with OnlyDividends

What will SN.L actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Health Score, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.